Longevity News

Mortality trends in diabetes with proxy-defined steatotic liver disease in the United States, 1999–2023

Source: Frontiers - Health • Published: 12 Jun 2026, 00:00

Mortality trends in diabetes with proxy-defined steatotic liver disease in the United States, 1999–2023

Review national mortality trends examining overlapping diabetes and proxy-defined metabolic steatotic liver disease and the study's methodological approach.

Key Takeaways
  • However, contemporary clinical MASLD criteria cannot be directly applied in national death-certificate data
  • This study was deemed exempt from institutional review board review because it used deidentified
  • Records suppressed by CDC WONDER for confidentiality were excluded from analysis
Read Original Source